Lack of association between maternal antibody and protection of African infants from malaria infection

Infection and Immunity

Volumn 68, Issue 10, 2000, Pages 5856-5863

  Riley, E M ^a   Wagner, G E ^a   Ofori, M F ^a   Wheeler, J G ^a   Akanmori, B D ^a   Tetteh, K ^a   McGuinness, D ^a   Bennett, S ^a   Nkrumah, F K ^a   Anders, R F ^a   Koram, K A ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; MATERNAL ANTIBODY; MEMBRANE ANTIGEN; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 2;

ADULT; AFRICA; ANTIBODY TITER; ARTICLE; GHANA; HUMAN; INFANT; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALARIA; NONHUMAN; PARASITE TRANSMISSION; PASSIVE IMMUNIZATION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE FACTORS; ANIMAL; ANTIBODIES, PROTOZOAN; FEMALE; GHANA; HUMAN; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; MALARIA, FALCIPARUM; MIDDLE AGE; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PREVALENCE; PROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T;

EID: 0033801240     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.10.5856-5863.2000     Document Type: Article

References (34)

1. Lack of association between levels of transplacentally acquired Plasmodium falciparum-specific antibodies and age of onset of clinical malaria in infants in a malaria endemic area of Nigeria
2. Malaria infection, morbidity and transmission in two ecological zones in Southern Ghana
3. Relationship between humoral response to Plasmodium falciparum merozoite surface antigen-2 and malaria morbidity in a highly endemic area of Papua New Guinea
4. Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria
5. Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity
6. Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi
7. An analysis of malaria parasite rates in infants: 40 Years after Macdonald
8. A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19 kilodalton domain of Plasmodium falciparum in pregnant women and infants: Associations with febrile illness, parasitaemia and anaemia
9. Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein
10. Seroepidemiological studies of malaria in pregnant women and newborns from coastal El Salvador
11. Measurement of Plasmodium falciparum growth rate in vivo: A test of malaria vaccines
12. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19kDa C-terminal fragment of the merozoite surface antigen, PfMSP1
13. The collectins in innate immunity
14. Rapid and simple method for isolating malaria DNA from fingerprick samples of blood
15. Milk diet, p-aminobenzoic acid and malaria (P. berghei): Preliminary communication
16. Relationship between maternally derived anti-Plasmodium falciparum antibodies and risk of infection and disease in infants living in an area of Liberia, West Africa, in which malaria is highly endemic
17. Plasmodium falciparum malaria in the first year of life in an area of intense and perennial transmission
18. Antibodies against Plasmodium falciparum vaccine candidates in infants in an area of intense and perennial transmission: Relationships with clinical malaria and with entomological inoculation rates
19. The analysis of malaria parasite rates in infants
20. Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection
21. The development and maintenance of immunity to malaria in highly endemic areas
22. Clinical case definitions for malaria: Clinical malaria associated with very low parasite densities in African infants
23. Maintaining the immunological balance in parasitic infections: A role for TGFb?
24. Effects of foetal haemoglobin on susceptibility of red cells to Plasmodium falciparum
25. Recognition of dominant T cell stimulating epitopes from the circumsporozoite protein of Plasmodium falciparum and relationship to malaria morbidity in Gambian children
26. Immune recognition of the malaria vaccine candidate antigen Pf155/RESA is associated with resistance to clinical disease: A prospective study in a malaria endemic region of West Africa
27. Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen of Plasmodium falciparum are associated with reduced malaria morbidity
28. A seroepidemiological study to evaluate the role of passive maternal immunity to malaria in infants
29. Allelic dimorphism in a surface antigen gene of the malaria parasite isolated from Plasmodium falciparum merozoites
30. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): Increasing prevalence with age and association with clinical immunity to malaria
31. Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and predominantly of the immunoglobulin G3 subclass
32. The Dielmo Project: A longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal
33. High incidence of asymptomatic malaria infections in a birth cohort of children under I year of age in Ghana, detected by multicopy gene polymerase chain reaction
34. Genetic analysis of the human malaria parasite Plasmodium falciparum